-
GEN – Genetic Engineering & Biotechnology News2 weeks agoEgg-Based Biologics Drive Neion Bio Pharma Deal
Neion Bio has emerged from stealth mode and signed its first co-development and supply agreement with an unnamed major global pharmaceutical company. Neion’s Raptor platform products...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoNanoplastics Released by ‘Eco-Friendly’ Bioplastics May Slow Fetal Development in Mice
The results of a study headed by teams at Anhui Medical University and Fudan University has found that when the “eco-friendly” bioplastic, polylactic acid (PLA), biodegrades,...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Antibodies Connect Cancer with Autoimmune Brain Disease
The link between cancer and brain function, specifically emotion and motivation is well documented. The connection of immune response to brain tissue is less well understood....
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: HHS convenes health care execs, motivational speaker on panel to modernize health care
WASHINGTON — A motivational coach, a venture capitalist who worked with health secretary Robert F. Kennedy Jr.’s son, and a number of health care executives whose...
-
AI & Machine Learning in Biotechnology2 weeks agoEli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned....
-
Endpoints News2 weeks ago
Biopharma industry pushes back on FDA’s ‘America First’ user fee proposals
Biopharma industry representatives are taking issue with some of the FDA’s more political proposals in the next round of user fee agreements, particularly ones that would...
-
Endpoints News2 weeks ago
Recordati says it’s received a $12B+ takeover bid
Milan-based Recordati confirmed Thursday that it has received a buyout offer north of $12 billion. The company said in a press release that private equity firm...
-
Fierce Biotech2 weeks ago
Chutes & Ladders—Tang takes over Aurinia after FDA brouhaha
Seasoned biotech takeover titan Kevin Tang has struck again. After serving as board chair of Aurinia since 2024, Tang has now ascended to the CEO spot...
-
Endpoints News2 weeks ago
UCB picks Georgia for $2B biologics site; AbbVie exec visits China
UCB has selected Gwinnett County, GA, as the location for its new biologics factory. The 460,000-square-foot facility is expected to cost $2 billion and will supply...
-
Endpoints News2 weeks ago
New tech, familiar problems
I’ve been on the hunt for a referral to see a new physical therapist. So I decided to try out Doctronic, which markets itself as an...
High-Throughput Platform for Fast-Acting Covalent Protein Therapies
Terns rebuffed a higher bid before selling to Merck
